SAGE-2 product is a result from years’ of extensive research of Interface Biology and international collaborations.   It provides a new strategy of virus disinfecting, which consists of three defending lines working synergistically to inhibit the adsorption of virus particles on the cell surface, block the pathway of virus particle resembling, and strengthen body’s immune system. Results of challenge studies of SAGE-2 prototype conducted in the USA shown activities against human influenza A. 

There is still no treatment for virus infection：Despite intensive screening of many thousands of substances for anti-influenza activity, no real drug has ever been developed that can really cure the infection of viruses.  Inhibition of virus particles’ attachment on cell surface is trend of current anti-virus research.  While the mechanism of such a drug is to block the entering of virus into cells, at the time a patient found symptom of virus infections it will always be too late to use the drug for the purpose it to be administrated.  Because all anti-virus drugs are chemically synthesized, they are toxic to human body at certain dosage level. 

Modern life couldn’t avoid contacting with viruses, especially in cities. Influenza virus threatens people all over the world, because it becomes prevalent on a global scale once in several years, resulting in a large number of victims.  Throughout recorded history influenza has remained a widespread, unpredictable disease with high morbidity and mortality. Every year, influenza epidemics are responsible for an average of approximately 20,000 deaths in the United States.

Warning  Although SAGE-2 was developed through a new anti-virus strategy and might possess anti-virus function to some individual the product is not intended to be a drug.  Should you feel any disease symptom and/or virus infection, please consult your doctor immediately.